Stocks


 Kalkine: ASX300 Outlook: Traders Boost Rate Cut Bets After Retail Sales Slip

Kalkine: ASX300 Outlook: Traders Boost Rate Cut Bets After Retail Sales Slip

May 30, 2025 03:47 PM AEST| By Team Kalkine Media

Highlights,Traders increase expectations for RBA rate cuts,April retail sales unexpectedly decline,Interest grows around ASX dividend stocks,Traders are ramping up expectations for interest rate cuts by the Reserve Bank of Australia (RBA) following a...

 Kalkine| Tamboran Advances SS Pilot Project Amid Broader Gains in ASX 200 Energy Sector

Kalkine| Tamboran Advances SS Pilot Project Amid Broader Gains in ASX 200 Energy Sector

May 30, 2025 03:38 PM AEST| By Team Kalkine Media

Highlights,Tamboran Resources Corporation (NYSE:TBN), (ASX:TBN) completes first tranche of PIPE funding,Capital to be used for drilling and development at Shenandoah South Pilot Project,Second tranche expected to follow, subject to approvals,The ener...

 Kalkine| ASX 200 Uranium Stocks React as Trump Signs Nuclear Energy Orders

Kalkine| ASX 200 Uranium Stocks React as Trump Signs Nuclear Energy Orders

May 30, 2025 03:35 PM AEST| By Team Kalkine Media

Highlights,US executive orders promote nuclear energy expansion and enriched uranium independence,Australia’s uranium reserves gain focus amid global supply chain shifts,ASX uranium companies including ASX:BOE, ASX:DYL, ASX:T92, ASX:REC respond to re...

 Kalkine| ASX 200 Healthcare Stock Ramsay Soars After Strategic Board Appointment

Kalkine| ASX 200 Healthcare Stock Ramsay Soars After Strategic Board Appointment

May 30, 2025 03:28 PM AEST| By Team Kalkine Media

Highlights,Ramsay Health Care (ASX:RHC) appoints Craig Drummond as Non-Executive Director, effective from July,Market responds with strong share movement amid positive sentiment in the healthcare sector,Broader transformation and governance focus ref...

 Kalkine: Catapult Group Soars to Record High: Strong Earnings Forecast Propels ASX200 Tech Player

Kalkine: Catapult Group Soars to Record High: Strong Earnings Forecast Propels ASX200 Tech Player

May 30, 2025 03:11 PM AEST| By Team Kalkine Media

Highlights,Catapult hits record high amid strong growth outlook,Projected earnings margin to nearly triple by FY27,Revenue and earnings expected to grow at a robust pace,Catapult Group International (ASX:CAT) saw its share price skyrocket over 10% on...

 Kalkine | ASX 200: ASX Introduces New Pricing Policy for Clearing and Settlement Services

Kalkine | ASX 200: ASX Introduces New Pricing Policy for Clearing and Settlement Services

May 30, 2025 03:03 PM AEST| By Team Kalkine Media

Highlights,ASX to implement Building Block Method to guide clearing and settlement pricing,Annual pricing reviews and independent verification to ensure revenue alignment,First possible fee adjustment under new rules set after a defined moratorium pe...

 Kalkine| ASX 200 Biotech Stock Recce Pharmaceuticals (ASX:RCE) Secures China Patent for Antibacterial Advancements

Kalkine| ASX 200 Biotech Stock Recce Pharmaceuticals (ASX:RCE) Secures China Patent for Antibacterial Advancements

May 30, 2025 02:20 PM AEST| By Team Kalkine Media

Highlights,Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) receives patent grant in China for RECCE 327 and RECCE 529,Patent strengthens global protection covering use, administration, and manufacturing methods,Company progresses with trials across So...

 Kalkine: dorsaVi Expands ViSafe+ Reach with SANO Health in New ASX200 Industry Partnership

Kalkine: dorsaVi Expands ViSafe+ Reach with SANO Health in New ASX200 Industry Partnership

May 30, 2025 02:05 PM AEST| By Team Kalkine Media

Highlights,dorsaVi signs three-year tech supply agreement with SANO Health,ViSafe+ tech to enhance safety in remote mining operations,Deal supports dorsaVi’s global expansion in mining and transport sectors,Motion technology company dorsaVi (ASX:DVL)...

 Kalkine: Cavalier Resources Moves Closer to Crawford Gold Project Launch Amid ASX200 Momentum

Kalkine: Cavalier Resources Moves Closer to Crawford Gold Project Launch Amid ASX200 Momentum

May 30, 2025 02:00 PM AEST| By Team Kalkine Media

Highlights,Cavalier nears $17M funding deal for Crawford gold project,Revised PFS supports strong financial metrics for Stage 1,Native Title discussions and approvals underway,Cavalier Resources (ASX:CVR) is progressing towards a key funding mileston...

 Kalkine: Mining Fee Hike Sparks Industry Backlash: Potential Setback for Victoria’s Role in ASX200 Mining Landscape

Kalkine: Mining Fee Hike Sparks Industry Backlash: Potential Setback for Victoria’s Role in ASX200 Mining Landscape

May 30, 2025 01:49 PM AEST| By Team Kalkine Media

Highlights,Victorian government proposes significant mining fee hikes,Industry flags risks to future mining investment in the state,Concerns raised over broader economic impact, including housing,Victoria’s mining sector is under pressure as the stat...

 Kalkine: Lynas Seals Malaysian Rare Earths Supply Deal, Adding Momentum to ASX200 Index

Kalkine: Lynas Seals Malaysian Rare Earths Supply Deal, Adding Momentum to ASX200 Index

May 30, 2025 01:41 PM AEST| By Team Kalkine Media

Highlights,Lynas signs supply deal in Malaysia,Rare earths sector gains momentum,ASX dividend stocks in focus,Lynas Rare Earths (ASX:LYC) has sparked fresh interest on the ASX200 after announcing a strategic supply agreement in Malaysia, marking a ke...

 Kalkine: Why Downer EDI (ASX:DOW) is Gaining Momentum in the ASX200

Kalkine: Why Downer EDI (ASX:DOW) is Gaining Momentum in the ASX200

May 30, 2025 01:37 PM AEST| By Team Kalkine Media

Highlights,DOW shares up 15.3% YTD on infrastructure strength,Backed by long-term government contracts and stable revenue,Offers consistent dividends, appealing for income investors,The industrials sector on the ASX has been buzzing in 2025, and,Down...

 Recce Pharmaceuticals’ China Patent Win Bolsters Antibacterial Strategy Amid Expanding ASX200 Opportunities

Recce Pharmaceuticals’ China Patent Win Bolsters Antibacterial Strategy Amid Expanding ASX200 Opportunities

May 30, 2025 01:36 PM AEST| By Team Kalkine Media

Highlights,Recce secures China patent for RECCE 327 and RECCE 529,Phase III trials underway in Asia and planned in the US,Strategic move aligns with ASX200 index growth outlook,Recce Pharmaceuticals Ltd (ASX:RCE) has taken a significant step forward...

 Kalkine: Wesfarmers and Flight Centre: How These ASX200 Stocks Are Tracking Against Historical Averages

Kalkine: Wesfarmers and Flight Centre: How These ASX200 Stocks Are Tracking Against Historical Averages

May 30, 2025 01:33 PM AEST| By Team Kalkine Media

Highlights,WES share price shows strong momentum in 2025,FLT trading well below historical valuation metrics,Easy metrics help assess current value of these ASX200 names,Investors often seek simple yet effective ways to evaluate prominent shares on t...

 Kalkine: Coles Group’s Strong 2025 Start: How This ASX200 Giant Offers Stability and Steady Income

Kalkine: Coles Group’s Strong 2025 Start: How This ASX200 Giant Offers Stability and Steady Income

May 30, 2025 01:32 PM AEST| By Team Kalkine Media

Highlights,Coles shares up 14.1% in 2025,Consistent dividends with defensive appeal,Stability supported by strong market presence,The share price of Coles Group Ltd (ASX:COL) has jumped 14.1% since the beginning of 2025, drawing fresh attention to on...

 Kalkine: Lynas Taps Into Malaysia’s Rare Earths Potential in New ASX200 Collaboration

Kalkine: Lynas Taps Into Malaysia’s Rare Earths Potential in New ASX200 Collaboration

May 30, 2025 01:31 PM AEST| By Team Kalkine Media

Highlights,Lynas signs MoU with Malaysia’s Kelantan state for rare earths supply,Partnership focuses on developing local rare earths value chain,MoU paves way for potential feedstock supply to Lynas’ Malaysian facility,Lynas Rare Earths (ASX:LYC), a...

 Kalkine: Prescient’s PTX-100 Enters Phase 2A Trial for Rare Lymphoma, Boosting ASX200 Biotech Momentum

Kalkine: Prescient’s PTX-100 Enters Phase 2A Trial for Rare Lymphoma, Boosting ASX200 Biotech Momentum

May 30, 2025 01:31 PM AEST| By Team Kalkine Media

Highlights,Prescient begins Phase 2A trial of PTX-100 for rare lymphoma,Drug shows promising safety and response in earlier studies,Orphan and fast track FDA designations could speed development,Prescient Therapeutics (ASX:PTX) has officially commenc...

 Kalkine: TCL vs FMG: Which ASX200 Stock Offers Better Value in 2025?

Kalkine: TCL vs FMG: Which ASX200 Stock Offers Better Value in 2025?

May 30, 2025 01:29 PM AEST| By Team Kalkine Media

Highlights,TCL sees modest gains; FMG lags near 52-week low,FMG’s strong dividend yield and low debt stand out,Both are key players in the ASX200 dividend landscape,In the dynamic world of ASX200 stocks, comparing companies like Transurban Group (ASX...

 Kalkine: Solid Moves in the ASX200: SOL and TLS Shares Gain Ground in 2025

Kalkine: Solid Moves in the ASX200: SOL and TLS Shares Gain Ground in 2025

May 30, 2025 01:27 PM AEST| By Team Kalkine Media

Highlights,SOL shares rise 8.1% in 2025,TLS rebounds 40.6% from 52-week low,Growing dividend yields attract attention,As the ASX200 index continues to evolve in 2025, some long-standing names are showing notable momentum. Among them, Washington H. So...

 Kalkine: Is Commonwealth Bank (ASX:CBA) Overvalued? Here’s What PE & Dividend Models Say | ASX200 Insight

Kalkine: Is Commonwealth Bank (ASX:CBA) Overvalued? Here’s What PE & Dividend Models Say | ASX200 Insight

May 30, 2025 01:22 PM AEST| By Team Kalkine Media

Highlights,Two valuation models suggest current CBA share price exceeds estimated intrinsic value,PE ratio comparison shows a significant premium to sector average,Dividend-based valuation,indicates,a more conservative price estimate,The Commonwealth...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.